Loading viewer...
earnings
Format: PDF earnings
Immunocore presented its 2Q and 1H 2024 financial results and business updates, highlighting progress across oncology, autoimmune, and infectious disease therapeutic areas. The presentation covered KIMMTRAK commercialization growth opportunities, pipeline development, and strategic pillars for advancing immunomodulating medicines.
earnings
15 Pages
El Paso Electric Company
African Export-Import Bank H1 2021 Results Investor Presentation
earningsearnings
24 Pages
African Export-Import Bank
Qantas Airways FY24 Results Supplementary Presentation 2024
earningsearnings
36 Pages
Qantas Airways Limited